Executive Blood Testing Panel

Comprehensive executive blood panel covering metabolic, haematological, lipid, liver, renal, tumour marker, and disease screening tests performed at Gleneagles Hospital's on-site laboratory.

The executive blood testing panel at Gleneagles Hospital represents the diagnostic core of its health screening programme, drawing on the hospital's ISO 15189-accredited on-site laboratory for fast, high-accuracy results. The panel is structured in layers: an essential metabolic screen covers full blood count (FBC) with differential, erythrocyte sedimentation rate, fasting plasma glucose, and HbA1c for diabetes risk; a lipid panel assesses total cholesterol, HDL, LDL, triglycerides, and the total:HDL ratio as a cardiovascular risk index; liver function tests evaluate ALT, AST, albumin, total protein, bilirubin, and alkaline phosphatase; renal function tests include creatinine, urea, and eGFR; thyroid function is assessed via TSH and free T4. Disease serology covers hepatitis B (HBsAg, anti-HBs, anti-HBc), hepatitis C antibody, HIV, syphilis (VDRL/TPHA), and H. pylori antibody where appropriate. Tumour markers included in the executive panel typically encompass CEA (colorectal and general oncology), AFP (hepatocellular), CA 19-9 (pancreatic), CA 125 (ovarian, women), CA 15-3 (breast, women), PSA and free PSA (prostate, men), and beta-hCG where indicated. Blood is drawn by Gleneagles nursing staff during the morning fasting appointment, and results are typically ready within three to four hours for same-day physician review. The depth and breadth of the panel make it a meaningful annual surveillance tool for early detection of metabolic, infectious, and oncological conditions.